Comparison of Lubiprostone and Placebo for the Relief of Constipation From Constipating Medications
Status:
Terminated
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
Constipation from medications is a serious and common condition. Lubiprostone has properties
that make it a candidate drug. One hundred volunteers with constipation who are taking
medications known to cause constipation will be randomized to take lubiprostone or placebo
for 28 days. Therapeutic outcome will be evaluated by investigator and study subject
assessment.